Evidence map›Paper›PMID 33035597›Full record

ArticleDiabetes research and clinical practice2020

Long-term metformin treatment and risk of peripheral neuropathy in older Veterans.

Monica C Serra, Vijaya Kancherla, Anjali Khakharia, Latricia L Allen, Lawrence S Phillips, Mary K Rhee, Peter W F Wilson, Camille P Vaughan

Open access · greenAbstract read
In one paragraph

Article in Diabetes research and clinical practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 25 citations in OpenAlex.

  1. Trial
  2. Reframing Micronutrient Deficiencies for Modern times: A Review.Journal of general internal medicine · 2025
    Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Monica C SerraDivision of Geriatrics, Gerontology & Palliative Medicine and the Sam & Ann Barshop Institute for Longevity & Aging Studies, UT Health San Antonio, San Antonio, TX, USA; Department of Veterans Affairs, San Antonio Geriatric Research Education and Clinical Center, South Texas VA Health Care System, San Antonio, TX, USA. Electronic address: serram@uthscsa.edu.
Vijaya KancherlaDepartment of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.
Anjali KhakhariaDivision of General Medicine and Geriatrics, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Latricia L AllenDivision of General Medicine and Geriatrics, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA; Department of Veterans Affairs, Birmingham/Atlanta Geriatric Research Education and Clinical Center, Decatur, GA, USA.
Lawrence S PhillipsAtlanta VA Health Care System, Decatur, GA, USA; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Mary K RheeAtlanta VA Health Care System, Decatur, GA, USA; Division of Endocrinology, Metabolism and Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Peter W F WilsonAtlanta VA Health Care System, Decatur, GA, USA; Division of Cardiology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Camille P VaughanDivision of General Medicine and Geriatrics, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA; Department of Veterans Affairs, Birmingham/Atlanta Geriatric Research Education and Clinical Center, Decatur, GA, USA.
Atlanta VA Health Care System · USEmory University · USGeriatric Research Education and Clinical Center · USSouth Texas Veterans Health Care System · US

Funding

Glycemia Reduction Approaches in Diabetes: A comparative effectiveness studyU01DK098246 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI KRAUSE-STEINRAUF, HEIDI, LACHIN, JOHN M · 2012 to 2022
$238.9M
Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
Screening for IGT: Glucose Challenge vs Predictive ModelR18DK066204 · NIDDK · EMORY UNIVERSITY · PI PHILLIPS, LAWRENCE S · 2004 to 2007
$2.9M
Vitamin D for Type 2 Diabetes (D2D trial)U34DK091958 · NIDDK · TUFTS MEDICAL CENTER · PI PITTAS, ANASTASSIOS G · 2011 to 2012
$792k
Reach, Outcomes and System Impacts of the VA's National Weight Loss Program, MOVER21DK099716 · NIDDK · EMORY UNIVERSITY · PI PHILLIPS, LAWRENCE S · 2014 to 2015
$321k
Latent tuberculosis infection and risk of type 2 diabetes mellitus in US veteransR03AI133172 · NIAID · GEORGIA STATE UNIVERSITY · PI MAGEE, MATTHEW JAMES · 2018 to 2019
$158k
Diabetic Complications and Genetic Variants in the Million Veterans ProgramI01CX001737 · VA · VETERANS HEALTH ADMINISTRATION · PI PHILLIPS, LAWRENCE S · 2019 to 2023
–
Behavioral therapy to treat urinary symptoms in Parkinson's diseaseIK2RX000747 · VA · VETERANS HEALTH ADMINISTRATION · PI VAUGHAN, ELIZABETH CAMILLE · 2012 to 2016
–
Machine Learning and Longitudinal Analyses of Metformin Response Among VeteransIK2CX001907 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI RAGHAVAN, SRIDHARAN · 2019 to 2023
–
CSRD VA I01 CX001737CSRD VA IK2 CX001907NCATS NIH HHS UL1 TR002378NIAID NIH HHS R03 AI133172NIDDK NIH HHS R18 DK066204NIDDK NIH HHS R21 DK099716NIDDK NIH HHS U01 DK098246NIDDK NIH HHS U34 DK091958RRD VA IK2 RX000747
6 · The paper itself

Abstract

aimOur objective was to assess whether increased duration of metformin therapy is associated with incident peripheral neuropathy (PN) in older Veterans with diabetes.

methodsUsing national Veterans Affairs registry data from 2002 to 2015, we examined Veterans (50 + years) with diabetes. Long-term metformin therapy was defined as prescription ≥ 500 mg/day, filled for ≥ 6 consecutive months. Metformin therapy duration was examined both as continuous and categorical measures. Incident PN was defined by medical chart review. We estimated unadjusted and adjusted (variables selecteda priori)odds ratios (OR) and 95% confidence intervals (CI) using logistic regression.

resultsThe study included n = 210,004 individuals (mean ± SD: age: 66.2 ± 8.4 yrs, 96% male) prescribed metformin for 47.0 ± 34.0 months. Nineteen percent developed PN during follow-up. After adjusting for age, body mass index, duration of time receiving health care within the VA, smoking status, alcohol abuse, and vitamin B12 testing and treatment, the number of months of metformin treatment was associated with elevated odds for incident PN (aOR (metformin treatment - continuous) = 1.009 (95% CI = 1.009, 1.010); aOR (metformin treatment - categorical (ref: 6-<18 months): 18-<44.1 months = 1.57 (1.51-1.63), 44.1-<61 months = 2.05 (1.97-2.14), 61 + months = 2.69 (2.58-2.79), all p-values < 0.0001).

conclusionOur study suggests that Veterans treated for at least 18 months with metformin are approximately 2-3 times more likely to develop PN than those treated at least six, but<18 months. Future studies are needed to determine whether the association we found may be due to a decline in vitamin B12 status following metformin initiation.

Indexed as

AgedAlcoholismBody Mass IndexDiabetes Mellitus, Type 2Diabetic NeuropathiesFemaleHumansHypoglycemic AgentsLogistic ModelsMaleMetforminMiddle AgedRetrospective StudiesRisk FactorsSmokingTime FactorsHypoglycemic AgentsMetforminVitamin B 12AgingMetforminType 2 diabetesVeteranVitamin B12

Identifiers

PMID33035597
PMCPMC8015419
OpenAlexW3092435214

What OpenQuestion holds

Texttitle and abstract
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.